About Moolec Science S.A.
https://moolecscience.comMoolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America.
CEO
Alejandro Antalich
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2026-01-05 | Reverse | 1:15 |
| 2025-05-14 | Reverse | 1:10 |
Price Target
About Moolec Science S.A.
https://moolecscience.comMoolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2024 | $2.64M ▲ | $1.39M ▼ | $-2.43M ▼ | -91.84% ▲ | $-0.9 ▼ | $-1.15M ▼ |
| Q1-2024 | $1.56M ▲ | $2.12M ▼ | $-1.92M ▲ | -123.02% ▲ | $-0.75 ▲ | $-1.07M ▲ |
| Q4-2023 | $1.52M ▼ | $2.87M ▲ | $-2.54M ▼ | -166.47% ▼ | $-1.05 ▼ | $-2.36M ▼ |
| Q3-2023 | $2.11M ▲ | $2.13M ▲ | $-1.4M ▲ | -66.46% ▲ | $-0.6 ▲ | $-627.06K ▲ |
| Q2-2023 | $252.11K | $1.97M | $-1.78M | -707.42% | $-0.75 | $-1.73M |
What's going well?
Revenue surged 70% and the company managed to cut operating expenses sharply. If this sales momentum continues and costs are brought under control, profitability could improve in future quarters.
What's concerning?
The company is losing money on every sale, with gross margins turning negative and net losses growing. High interest costs and ongoing losses raise questions about how long the company can sustain itself.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2024 | $1.93M ▼ | $31.38M ▼ | $28.58M ▲ | $2.8M ▼ |
| Q1-2024 | $3.61M ▼ | $32.56M ▼ | $26.87M ▼ | $5.69M ▼ |
| Q4-2023 | $5.39M ▲ | $34.79M ▲ | $27.97M ▲ | $6.82M ▲ |
| Q3-2023 | $4.25M ▲ | $25.95M ▲ | $19.31M ▲ | $6.64M ▼ |
| Q2-2023 | $1.83M | $21.32M | $14.64M | $6.68M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2024 | $-2.43M ▼ | $-890.48K ▲ | $-298.86K ▼ | $-529.9K ▲ | $-1.68M ▲ | $-1.19M ▼ |
| Q1-2024 | $-1.92M ▲ | $-1.13M ▼ | $-59.74K ▼ | $-542.42K ▼ | $-1.78M ▼ | $-1.19M ▼ |
| Q4-2023 | $-2.54M ▼ | $-1.04M ▲ | $-24.05K ▼ | $2.2M ▼ | $1.14M ▼ | $-1.07M ▲ |
| Q3-2023 | $-1.4M ▲ | $-2.64M ▲ | $112.48K ▲ | $4.82M ▼ | $2.55M ▲ | $-2.67M ▲ |
| Q2-2023 | $-1.78M | $-4.06M | $-128.13K | $4.97M | $847.89K | $-4.05M |
CEO
Alejandro Antalich
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2026-01-05 | Reverse | 1:15 |
| 2025-05-14 | Reverse | 1:10 |